JLEN Environmental Assets Group Ltd is investing GBP26.7 million in a glasshouse project, which will initially focus on growing cannabis for medical purposes.
The environmental infrastructure investment fund said a 2.1-hectare glasshouse will be built in the UK, close to one of the firm's anaerobic digestion plants. It added that the existing plant will "be upgraded to supply low carbon heat and power to the glasshouse via a private wire."
The London-based company said it expects the glasshouse to start production in 2023 and will be suited for a plethora of agricultural produce such as consumable crops and cut flowers.
JLEN explained that the initial focus will be on the "heavily regulated" tetrahydrocannabinol flower to supply UK-based pharmaceutical manufacturers.
To read the complete article, go to www.morningstar.co.uk